{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-017306","form_type":"8-K","ticker":"DYAI","cik":"0001213809","company_name":"DYADIC INTERNATIONAL INC","filed_at":"2025-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.955917+00:00","generated_at":"2026-05-17T04:24:20.047634+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Dyadic regains Nasdaq compliance, achieves $750K in milestones with Proliant & Inzymes","bullets":["Regained compliance with Nasdaq market value ($35M) and bid price ($1.00) rules after 10 consecutive days ending Sept 30 & Oct 2, 2025.","Received $500K milestone from Proliant for recombinant human albumin productivity; payment expected Q4 2025; commercial launch targeted late 2025/early 2026.","Received $250K milestone payment from Inzymes for dairy enzyme productivity improvements; first enzyme scale-up on track for late 2025 launch.","Signed term sheet for development of non-animal human alpha-lactalbumin for infant nutrition; sampling of bovine version underway.","Advancing commercialization of recombinant transferrin and DNase I with ongoing sampling and validation in research/diagnostic markets."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-017306","json":"https://secwatch.observer/filing/0001493152-25-017306.json","markdown":"https://secwatch.observer/filing/0001493152-25-017306.md","text":"https://secwatch.observer/filing/0001493152-25-017306.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213809/000149315225017306/0001493152-25-017306-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213809/000149315225017306/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:24:20.047634+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}